Valeant Pharma (NYSE: VRX) announced that its Board of Directors has appointed Jeffrey W. Ubben, Founder, Chief Executive Officer, and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE